FREEHOLD, N.J., May 25, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (NWLF) (OTCBB:NWLF) announced today that it will acquire Pharma Trials International (PTI) in a $1.5 Million deal that will provide entry and presence in the clinical research field. The transaction calls for NWLF to pay $1.5 Million in common stock. NWLF expects the deal, which is subject to audit, customary closing conditions and regulatory approvals, to close in the third quarter ending September 30, 2005.
